Related Experiment Videos
[Structure and function of blood-tissue barriers].
1Anatomisches Institut, Eberhard-Karls-Universität Tübingen, Germany.
Deutsche Medizinische Wochenschrift (1946)
|December 7, 2002
Summary
Drug delivery to organs is hindered by physiological barriers, such as the blood-brain barrier. Strategies to overcome these barriers involve opening them or modifying drug molecules for enhanced transport and therapeutic efficacy.
Area of Science:
- Pharmacology
- Cell Biology
- Physiology
Context:
- Systemic drug administration is often ineffective for reaching target organs due to physiological barriers.
- These barriers, including the blood-brain, blood-placenta, and blood-testis barriers, restrict the passage of large or hydrophilic molecules.
- Inflammation and tumors can compromise the integrity of these crucial blood-tissue barriers.
Purpose:
- To review the challenges posed by blood-tissue barriers in drug delivery.
- To explore strategies for enhancing drug transport across these barriers.
- To discuss the implications for pharmaceutical treatment of organs protected by barriers.
Summary:
- Blood-tissue barriers, formed by endothelial or epithelial cells with tight junctions, regulate molecular transport.
- These barriers exclude large or hydrophilic molecules, preventing systemic drugs from reaching parenchymal tissues.
- Drug delivery strategies include barrier opening (e.g., using bradykinin or mannitol) and drug modification (e.g., lipidization, liposomes, active transport coupling).
Impact:
- Understanding blood-tissue barriers is critical for developing effective treatments for diseases affecting protected organs.
- Novel drug delivery strategies are essential for overcoming transport limitations and improving therapeutic outcomes.
- Targeted drug delivery to specific organs requires both potent pharmaceuticals and specialized administration approaches.